SAINT MAUR DES FOSSÉS, France

Elodie Monteiro


 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elodie Monteiro: Innovator in Eye Disease Treatment

Introduction

Elodie Monteiro is a prominent inventor based in Saint Maur des Fossés, France. She has made significant contributions to the field of ophthalmology through her innovative research and development of chemical compounds aimed at treating eye diseases. Her work is particularly focused on conditions such as age-related macular degeneration and Stargardt's disease.

Latest Patents

Elodie Monteiro holds a patent for chemical compounds targeting the eye. This patent, which is a significant advancement in the treatment of eye diseases, discloses chemical compounds C that are derivatives of norbixin. These compounds have a specific tropism for the eye and are intended for use in altering the retinal pigment epithelium, thereby providing potential therapeutic benefits for mammals suffering from various eye conditions. She has 1 patent to her name.

Career Highlights

Throughout her career, Elodie has worked with notable organizations, including Biophytis and the Centre National de la Recherche Scientifique. Her experience in these institutions has allowed her to develop her expertise in the field of eye health and contribute to groundbreaking research.

Collaborations

Elodie has collaborated with esteemed colleagues such as Laurence Dinan and René Lafont. These partnerships have further enriched her research and have played a crucial role in advancing her innovative projects.

Conclusion

Elodie Monteiro is a trailblazer in the field of eye disease treatment, with her innovative patents and collaborations paving the way for future advancements. Her dedication to improving eye health through scientific research is commendable and highlights the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…